Dialysis world news

Societe Generale Downgrades Fresenius Medical Care AG Co. to Hold (FMS) - sleekmoney

Fresenius Medical Care AG & Co. (NYSE:FMS) was downgraded by Societe Generale from a “buy” rating to a “hold” rating in a research note issued to investors on Thursday, TheFlyOnTheWall.com reports.

Fresenius Medical Care AG & Co. (NYSE:FMS) traded up 0.91% on Thursday, reaching $41.15. The company’s stock had a trading volume of 78,366 shares. The company has a market cap of $25.07 billion and a P/E ratio of 23.66. The stock’s 50 day moving average price is $42.19 and its 200 day moving average price is $41.48. Fresenius Medical Care AG & Co. has a 12 month low of $32.40 and a 12 month high of $44.34.

Fresenius Medical Care AG & Co. (NYSE:FMS) last announced its quarterly earnings data on Thursday, July 30th. The company reported $0.40 EPS for the quarter, missing the consensus estimate of $0.42 by $0.02. During the same period in the prior year, the company posted $0.42 EPS. The business had revenue of $4.20 billion for the quarter, compared to analyst estimates of $4.13 billion. Fresenius Medical Care AG & Co.’s quarterly revenue was up 15.0% on a year-over-year basis. Equities research analysts forecast that Fresenius Medical Care AG & Co. will post $1.75 earnings per share for the current year.

Other research analysts also recently issued reports about the stock. Commerzbank AG downgraded Fresenius Medical Care AG & Co. to a “hold” rating in a report on Friday, May 29th. RBC Capital upped their price target on shares of Fresenius Medical Care AG & Co. from $35.00 to $40.00 and gave the company a “sector perform” rating in a research report on Friday, July 31st. Seven equities research analysts have rated the stock with a hold rating and three have given a buy rating to the stock. The stock presently has an average rating of “Hold” and a consensus price target of $41.10.

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) is a kidney dialysis company. The Company provides dialysis care services related to the dialysis treatment a patient receives with end-stage renal disease (ESRD), as well as other health care services. FMC AG & CO. KGAA also provides dialysis products for the treatment of ESRD, which includes manufacturing and distributing products, such as hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. The Company’s health care services, referred to as care coordination services, include pharmacy services, vascular, cardiovascular and endovascular specialty services, non-dialysis laboratory testing services, physician services, hospitalist and intensivist services, health plan services and urgent care services. The Company also offers a range of dialysis drugs.image

The Fly On The Wall


Hemodialysis University at Chicago, October 1-3, 2015
The International Society for Hemodialysis is pleased to announce Hemodialysis University 2015 in Chicago. The conference is designed for health professionals involved in direct care provision to patients receiving dialysis, including nephrologists, nephrology fellows, nephrology nurses, nurse practitioners, and patient care technicians. Chicago is absolutely lovely to visit in early Chicago, and it's a wonderful program! Please register now.


Queen Mothers appeal for assistance for V/R dialysis project - GhanaWeb

Regional News of Saturday, 15 August 2015



Myjoy Voltya Dailysis PateintsVolta Regional Hospital has no dialysis machine centre

Patients in the Volta Region who have kidney related ailments and require dialysis have no choice than to travel to Korle Bu in Accra for dialysis.

This is because the region does not have a dialysis machine at its major referral Centre - the Volta Regional Hospital.

The agony of some of these patients is that they are sometimes unable to access the services due to the queues at Korle Bu. Sometimes patients return to the Volta Region unattended to.

According to the Medical Director of the Volta Regional Hospital, Dr John Tampouri, the hospital a lot of renal cases which they have to refer eto Kole Bu Teacching Hospital very time.

In their bid to reduce the burden of their clients, the Volta Regional Hospital has gone into partnership with DMed Healthcare AG Limited for the provision of dialysis machines to the hostpital.

The machines are expected to be installed in few weeks and after a water treatment plant has been installed.

To help get the water treatment plant for the dialysis machines, the Queen Mothers Asogli, with the support of the paramount Queen Mother Mamaga Akua Dei, have begun soliciting funds for the hospital to ensure that the water treatment plant required for the dialysis machines to function at maximum capacity is installed as early as possible.

Mama Atrato II, Queen Mother of Ho Dome is appealing to all benevolent organizations and individuals to assist.

She says it is necessary to get the dialysis centre running now considering the hustle people of the region go through to access dialysis machines at Korle Bu Teaching Hospital in Accra.

The cost of the water treatment plant is estimated at GHc 29, 000.00.


Google partnering with Dexcom in continuous glucose monitoring device.
Youth Health Mag: The partnership is strategic as each has something good to bring at the table. Dexcom has developed an FDA-approved technology called continuous glucose monitoring (CGM), which uses sensors to track glucose fluctuations underneath the skin all throughout the day. It is currently marketed as a complement to traditional monitors since it can provide more in-depth information. On the other hand, Google will provide the cloud-based system for the sensors. This means all readings by the device will be immediately uploaded into the cloud, which can then be accessed anytime and anywhere, as well as by concerned partners like physicians and patients.


JEFF EDELSTEIN: For Hamilton kidney dialysis patient, a living room solution - The Trentonian

JEFF EDELSTEIN: For Hamilton kidney dialysis patient, a living room solution
The Trentonian
And while a generation or two ago Greenberg's condition would have been a death sentence, these days Greenberg is … well, he's living his life almost exactly as he was before thanks to some nifty technology not all dialysis patients are aware of.


<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>

Page 10 of 2630
Share |
Copyright © 2024 Global Dialysis. All Rights Reserved.